Clinical Trials Browser

Phase 2 × Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma × tremelimumab × Clear all

NCT02937818 2024-06-07

A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer

Phase 2 Completed

72 enrolled 29 charts

Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma